The book closed one day earlier than planned on Wednesday, two of the sources said. The deal would have raised $211 million at the upper end of the indicated range. Intel and Alibaba Cloud launch competition to develop AI algorithm for detecting early signs of lung cancer, with LinkDoc providing CT scans to train. listings, seeking to raise around 200 million through its IPO. It had planned to sell 10.8 million shares between $17.50 and $19.50 each. LinkDoc was one of a steady stream of money-losing but fast-growing tech companies to file for U.S.
LinkDoc filed for an initial public offering in the United States last month and was due to price its shares after the U.S. The decision to pull the LinkDoc deal was due to the crackdown, the sources said. HONG KONG (July 8): Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States following Beijings clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. The company's product suite includes a digital continuous care platform for patients with critical diseases, an AI-enabled curation system for longitudinal medical data, and a precision life sciences platform for. It is the first known Chinese firm to pull back from its IPO plans since the crackdown began last week with an investigation by China’s cybersecurity regulator into ride-hailing giant Didi Global Inc just two days after it made its New York debut.īeijing said on Tuesday that it would strengthen supervision of all Chinese firms listed offshore, a sweeping regulatory shift that triggered a sell-off in U.S.-listed Chinese stocks. LinkDoc Technology provides a platform that structures cancer patient data to enable precision medicine and personalized care. Sources with direct knowledge of the matter have revealed that Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States following Beijing’s clampdown on overseas listings by domestic firms.
0 kommentar(er)
